GSA Capital Partners’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,502
Closed -$201K 2194
2016
Q4
$201K Buy
+2,502
New +$199K 0.01% 1596
2016
Q3
Sell
-8,380
Closed -$654K 2125
2016
Q2
$654K Sell
8,380
-5,662
-40% -$404K 0.04% 924
2016
Q1
$772K Buy
14,042
+1,250
+10% +$68.1K 0.05% 707
2015
Q4
$790K Sell
12,792
-72,232
-85% -$4.56M 0.04% 873
2015
Q3
$5.36M Buy
85,024
+62,962
+285% +$4.49M 0.26% 35
2015
Q2
$1.61M Sell
22,062
-23,402
-51% -$1.69M 0.06% 526
2015
Q1
$2.97M Buy
45,464
+5,250
+13% +$349K 0.12% 164
2014
Q4
$2.62M Sell
40,214
-154,238
-79% -$9.93M 0.18% 79
2014
Q3
$11.7M Buy
+194,452
New +$12.7M 0.62% 13
2014
Q2
Sell
-24,915
Closed -$1.63M 2068
2014
Q1
$1.63M Sell
24,915
-5,466
-18% -$356K 0.12% 171
2013
Q4
$1.88M Buy
30,381
+8,217
+37% +$476K 0.15% 111
2013
Q3
$1.19M Buy
22,164
+14,943
+207% +$770K 0.09% 267
2013
Q2
$329K Buy
+7,221
New +$313K 0.04% 820

Other funds holding STJ

GSA Capital Partners's STJ Position: Q1 2017 in Review

GSA Capital Partners sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,502 shares — an estimated $201K sold.

GSA Capital Partners first reported a position in STJ in Q2 2013 and held it in 13 quarters. The position peaked at $11.7M in Q3 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • GSA Capital Partners reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • GSA Capital Partners sold 2,502 St Jude Medical shares in Q1 2017, an estimated $201K.
  • GSA Capital Partners first reported a position in St Jude Medical in Q2 2013 and held it in 13 quarters.
  • GSA Capital Partners's St Jude Medical position peaked at $11.7M in Q3 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on GSA Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.